Apollo Endosurgery, Inc.
CIK 0001251769
Revenue (TTM)
$71.89M
+22.0% YoY
FY Mar 2023
Net Income (TTM)
−$36.94M
−61.4% YoY
FY Mar 2023
EPS Diluted (TTM)
−$0.98
−19.5% YoY
FY Mar 2023
Gross Margin
56.1%
FY Mar 2023
Operating Margin
-34.2%
FY Mar 2023
Net Margin
-51.4%
FY Mar 2023
Free Cash Flow (TTM)
−$26.4M
FY Mar 2023
Cash
$57M
FY Mar 2023
Total Debt
$33.96M
FY Mar 2023
Shares Outstanding
57.97M sh
FY Mar 2023